Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

IMPLANTEU Innovative approaches to implantation research in health and disease

Coordinator
Euvitro Slu, Spain
Runs
1 October 2024 to 30 September 2028
Status
Running
EU funding
€3.4m
Total cost
—
Partners
15 organisations in 8 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101169308

What the project is doing

In the project's own words, from its summary on CORDIS.

Implantation of the embryo in a receptive uterus is critical for mammalian reproduction, yet remains poorly understood. This challenge is particularly significant in human health, as up to two-thirds of human pregnancies are lost due implantation failure. In the agricultural sector, particularly in sustainable milk and meat production, understanding and improving embryo implantation is equally crucial. High peri-implantation mortality rates in livestock lead to lower efficiency, profitability, and environmental sustainability.

Much remains unknown about the molecular pathways and regulatory mechanisms of embryo-endometrial interactions in humans and livestock species. For ethical and practical reasons, implantation cannot be adequately studied in vivo in human, and it remains challenging in most animal models. IMPLANTEU is an international community of researchers whose objectives are: 1) To develop a molecular blueprint of human implantation in health and disease; 2) To improve implantation fitness for food production mammals and 3) To develop an advanced toolkit for implantation research.

IMPLANTEU provides multi-species, multi-sector and multi-model molecular and system implantation research, integrating complementary expertise in reproductive and stem cells biology, medicine, physiology, ethics and law, and cutting-edge technologies such as stem cell-based embryo models, organoids, machine learning, and organ-on-chip. IMPLANTEU will train 13 doctoral candidates through research, innovation, secondments in academic and industrial environments, horizontal and focused courses, and interactions with stakeholders.

The findings generated through IMPLANTEU will contribute to the profound understanding of the embryonic and endometrial contribution to reproductive success, innovations in infertility treatment, animal production efficiency and sustainability, tissue bioengineering, pathogen-host interaction, reproductive toxicology, and stem cell biology.

Topics

Who is involved

OrganisationCityCountryRole
Euvitro SluBarcelonaSpainCoordinator
Dawn-Bio GmbHWienAustriaAssociatedpartner
Institut Fuer Molekulare Biotechnologie GmbHWienAustriaParticipant
Medizinische Universitat GrazGrazAustriaParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Universiteit GentGentBelgiumParticipant
SustainLABilityHeidelbergGermanyAssociatedpartner
Universitaetsklinikum Hamburg-EppendorfHamburgGermanyParticipant
Universitat Politecnica De ValenciaValenciaSpainParticipant
Ceva Sante Animale SALibourneFranceAssociatedpartner
University College Dublin, National University of Ireland, DublinDublinIrelandParticipant
Biomimx SRLMilanoItalyParticipant
Politecnico Di MilanoMilanoItalyAssociatedpartner
Universita Degli Studi Di MilanoMilanoItalyParticipant
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI